Point of Care Platform
Theracell Advanced Biotechnology, through its partnership with Orgenesis Inc. (NASDAQ: ORGS), a leading global biotech company focused on cell and gene therapies (CGTs), aims to establish point of care (“POCare”) centers at hospitals and medical institutions in Greece and in the region of South-East Europe. Theracell will actively participate in the clinical development of new therapies through to marketing authorization by the regulatory authorities.
The Orgenesis POCare platform offer cell and gene therapies in close proximity to medical centres with the goal of significantly improving the accessibility to advanced therapy medicinal products, by lowering the processing costs and eliminating the logistic and administrative challenges associated with centralized manufacturing of such therapies. Additionally, increased automation and utilization of proprietary technologies results in efficient and safe production of CGTs.